Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Accolade (ACCD)
NASDAQ:ACCD
Holding ACCD?
Track your performance easily
ACCD Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.08 - $13.93
Previous CloseN/A
Volume14.97M
Average Volume (3M)2.54M
Market Cap
$562.77M
Enterprise Value$323.71M
Total Cash (Recent Filing)$13.53M
Total Debt (Recent Filing)$15.91M
Price to Earnings (P/E)―
Beta1.64
Next Earnings
Apr 24, 2025EPS Estimate
0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.25
Shares Outstanding81,678,820
10 Day Avg. Volume3,422,067
30 Day Avg. Volume2,543,062
Standard Deviation0.22
R-Squared0.20
Alpha-0.04
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.26
Price to Cash Flow (P/CF)-14.40
P/FCF Ratio0.00
Enterprise Value/Market Cap0.58
Enterprise Value/Revenue0.72
Enterprise Value/Gross Profit1.69
Enterprise Value/Ebitda-2.22
Forecast
1Y Price Target
$8.16Price Target Upside18.60% Upside
Rating ConsensusHold
Number of Analyst Covering11
Accolade News
Bulls Say, Bears Say
Bulls Say
Acquisition PremiumThe acquisition by Transcarent represents a premium of approximately 110% compared to the previous closing price.
Growth And Scale AdvantagesThe acquisition is expected to bring scale advantages, a unified front-end platform, and potential synergies via AI.
Strategic SynergiesThe strategic acquisition is seen as logical and synergistic, enhancing AI capabilities in ACCD's operations.
Bears Say
Acquisition And ValuationTarget price has been reduced from $8 to $7.03, aligning with the proposed takeout price.
Financial GuidanceThe company is withdrawing its prior guidance for FY25 and will not host the previously scheduled call.
Market PerformanceACCD's shares were previously trading at a dislocation to intrinsic value due to generally negative Health IT sentiment.
---
Ownership Overview
9.73% Insiders
11.58% Mutual Funds
0.08% Other Institutional Investors
62.58% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ACCD FAQ
What was Accolade’s price range in the past 12 months?
Accolade lowest stock price was $3.08 and its highest was $13.93 in the past 12 months.
What is Accolade’s market cap?
Accolade’s market cap is $562.77M.
When is Accolade’s upcoming earnings report date?
Accolade’s upcoming earnings report date is Apr 24, 2025 which is in 83 days.
How were Accolade’s earnings last quarter?
Accolade released its earnings results on Jan 09, 2025. The company reported -$1.5 earnings per share for the quarter, missing the consensus estimate of -$0.324 by -$1.176.
Is Accolade overvalued?
According to Wall Street analysts Accolade’s price is currently Undervalued.
Does Accolade pay dividends?
Accolade does not currently pay dividends.
What is Accolade’s EPS estimate?
Accolade’s EPS estimate is 0.05.
How many shares outstanding does Accolade have?
Accolade has 81,678,820 shares outstanding.
What happened to Accolade’s price movement after its last earnings report?
Accolade reported an EPS of -$1.5 in its last earnings report, missing expectations of -$0.324. Following the earnings report the stock price went up 1.763%.
Which hedge fund is a major shareholder of Accolade?
Among the largest hedge funds holding Accolade’s share is ARK Investment Management LLC. It holds Accolade’s shares valued at 21M.
---
Accolade Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$8.16 (18.60% Upside)
$8.16 (18.60% Upside)
Blogger Sentiment
Bullish
ACCD Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 289.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 2.0%
Last 30 Days ▲ 12.5%
Last 30 Days ▲ 12.5%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-41.31%
12-Months-Change
Fundamentals
Return on Equity
-48.23%
Trailing 12-Months
Asset Growth
-17.57%
Trailing 12-Months
Company Description
Accolade
Accolade Inc offers technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits. it generates revenue through providing personalized health guidance solutions to members.
---
ACCD Company Deck
---
ACCD Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Accolade reported strong revenue and cash flow performance, with significant new wins and a robust cash position. However, challenges include potential delays in health plan deployments and increased pressure from ROI guarantees.Read More>---
ACCD Stock 12 Month Forecast
Average Price Target
$8.16
▲(18.60% Upside)
Technical Analysis
Best Analysts Covering ACCD
1 Year
1 Year Success Rate
4/5 ratings generated profit
1 Year Average Return
+55.12%
reiterated a buy rating 4 months ago
Copying Allen Lutz's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +55.12% per trade.
---